Bio Path | BPTH - Despesas Operacionais





Despesas Operacionais Alterar Data
Alterity Therapeutics Limited AUD 8.67M 893.38K 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Bio Path USD 488K 4.07M 2025-09
Cipla INR 60.98B 1.06B 2025-12
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 11.29M 1.51M 2025-12
CSL USD 5.7B 2.82B 2025-12
Grifols EUR 1.99B 217.4M 2025-12
Karyopharm Therapeutics USD 51.92M 9.9M 2025-12